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Objective: Hypothalamic arcuate proopiomelanocortin (Arc-POMC) neurons are involved in different physiological processes such as the
regulation of energy balance, glucose homeostasis, and stress-induced analgesia. Since these neurons heterogeneously express different
biological markers and project to many hypothalamic and extrahypothalamic areas, it is proposed that Arc-POMC neurons could be classified into
different subpopulations having diverse physiological roles. The aim of the present study was to characterize the contribution of the subpopulation
of Arc-POMC neurons cosecreting gamma-aminobutyric acid (GABA) neurotransmitter in the control of energy balance.
Methods: Arc-Pomc expression restricted to GABAergic-POMC neurons was achieved by crossing a reversible Pomc-deficient mouse line
(arcPomc) with a tamoxifen-inducible Gad2-CreER transgenic line. Pomc expression was rescued in the compound arcPomc/:Gad2-CreER
female and male mice by tamoxifen treatment at postnatal days 25 (P25) or 60 (P60), and body weight, daily food intake, fasting glycemia, and
fasting-induced hyperphagia were measured. POMC recovery was quantified by immunohistochemistry and semiquantitative RT-PCR. Neuro-
peptide Y (NPY) and GABAergic neurons were identified by in situ hybridization. Arc-POMC neurons projecting to the dorsomedial hypothalamic
nucleus (DMH) were studied by stereotactic intracerebral injection of fluorescent retrobeads into the DMH.
Results: Tamoxifen treatment of arcPomc/:Gad2-CreER mice at P60 resulted in Pomc expression in w23e25% of Arc-POMC neurons and
w15e23% of PomcmRNA levels, compared to Gad2-CreER control mice. Pomc rescue in GABAergic-POMC neurons at P60 normalized food intake,
glycemia, and fasting-induced hyperphagia, while significantly reducing body weight. Energy balance was also improved in arcPomc/:Gad2-
CreER mice treated with tamoxifen at P25. Distribution analysis of rescued POMC immunoreactive fibers revealed that the DMH is a major target site
of GABAergic-POMC neurons. Further, the expression of the orexigenic neuropeptide Y (NPY) in the DMH was increased in arcPomc/ obese mice
but was completely restored after Pomc rescue in arcPomc/:Gad2-CreER mice. Finally, we found thatw75% of Arc-POMC neurons projecting to
the DMH are GABAergic.
Conclusions: In the present study, we show that the expression of Pomc in the subpopulation of Arc-GABAergic-POMC neurons is sufficient to
maintain normal food intake. In addition, we found that DMH-NPY expression is negatively correlated with Pomc expression in GABAergic-POMC
neurons, suggesting that food intake may be regulated by an Arc-GABAergic-POMC / DMH-NPY pathway.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Overweight is caused by multiple factors leading to the disruption of
cerebral circuits that sense energy availability and regulate energy
balance [1]. Proopiomelanocortin (POMC) anorexigenic neurons,
located in the arcuate nucleus (Arc) of the hypothalamus, are the main
regulators of food intake and energy expenditure [2]. Recent studies
have shown that Arc-POMC neurons are heterogeneous and can be
divided into subpopulations expressing diverse biomarkers and neu-
rotransmitters [3e5]. However, the physiological roles of the different
subpopulations, their anatomical distribution and targets, remain
unknown.
POMC is a propeptide predominantly expressed in the pituitary gland
and the hypothalamus. After posttranslational processing, POMC gives
rise to bioactive products with different actions. In particular, hypo-
thalamic melanocortins a- and b-melanocyte-stimulating hormones
(a- and b-MSH) suppress food intake, stimulate energy expenditure,
and enhance insulin sensitivity through melanocortin receptor 4
(MC4R) [6]. Mutations in Pomc or Mc4r genes lead to severe hyper-
phagia and early-onset obesity in both humans and mice [7e13].
Moreover, diet-induced obesity triggers hypothalamic inflammation
and endoplasmic reticulum stress which, in turn, impairs POMC pro-
cessing, leading to decreased production of a-MSH and, consequently,
to hyperphagia and overweight [14e16]. Notably, the characterization
of POMC neurons and their circuits in mouse models has contributed to
the design and study of different drugs for the treatment of obesity and
type 2 diabetes, some of which are already available for patients [17e
22].
Arc-POMC neurons project to different hypothalamic areas involved in
energy balance such as the paraventricular (PVH), ventromedial, dor-
somedial (DMH), and lateral (LH) hypothalamic nuclei, as well as
extrahypothalamic regions involved in other functions like autonomic
control, reward, and analgesia [23e25]. The DMH is known to be
involved in the regulation of food intake and energy expenditure [26]. It
receives afferent projections from the Arc and, in turn, sends efferent
projections to the PVH and the LH [26]. Lesions of the DMH result in
hypophagia and weight loss, supporting a role for this region in the
stimulation of food intake [27]. Moreover, it has been shown that the
orexigenic neuropeptide Y (NPY) is involved in DMH induction of food
intake in lactating rats and in some models of obese mice [28e31].
Finally, there is some evidence showing that melanocortin receptors
mediate an inhibitory tone onto DMH-NPY expression [32]. However, a
link between Arc-POMC expression and DMH-NPY expression remains
to be established.
It has been shown that POMC neurons are heterogeneous regarding
their electrophysiological response to peripheral signals (e.g., glucose)
and the receptors they express (e.g., leptin, serotonin, insulin, and
estrogen receptors) [33e35]. Moreover, subsets of hypothalamic
POMC neurons express and corelease either gamma-aminobutyric
acid (GABA) or glutamate (Glu) [36e38], encompassing 45e54%
and 7e43% of POMC neurons, respectively [39,40]. Given the
antagonistic responses elicited by GABA and Glu in neuronal excit-
ability, it is speculated that these subpopulations carry out different
functions. Recent studies applying single-cell RNA sequencing showed
that Arc-POMC neurons can be classified into subpopulations with
different transcriptomic profiles [3e5]. In particular, Campbell `
showed that Arc-POMC neurons can be classified into three clusters.
While two of these clusters express mainly GABAergic markers (Gad1
and Gad2), the third one expresses principally a glutamatergic marker
(Vglut2). Interestingly, there is a preponderant response to the fasting
of GABAergic-POMC clusters, evidenced by changes in their gene2 MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. Texpression profiles [3]. However, the physiological roles of these
subpopulations in the regulation of energy homeostasis remain to be
elucidated. In the present study, we aimed to dissect the contribution
of the subpopulation of Arc-POMC neurons cosecreting GABA in the
control of energy balance by expressing Pomc exclusively in
GABAergic-POMC neurons of Pomc-deficient mice.
2. MATERIALS AND METHODS
2.1. Animal care
Mice were kept under standard laboratory conditions, with controlled
photoperiod (lights on from 7 a.m. to 7 p.m.), tap water, and standard
lab chow available ad libitum. Mice were weaned at P21. All pro-
cedures were approved by the Institutional Animal Care and Use
Committee of the Facultad de Medicina, Universidad de Buenos Aires.
2.2. Mouse lines
Ai14:Gad2-CreER. To characterize the expression pattern of Cre
recombinase in the knock-in Gad2-CreERT2 mouse line (Gad2-CreER,
for simplicity), we used Ai14:Gad2-CreER mice obtained by crossing
heterozygous Gad2-CreER (Gad2tm1(cre/ERT2)Zjh; The Jackson Labora-
tory, stock: 010,702 [41]) and homozygous Ai14 mice (B6. Cg-
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, The Jackson Laboratories, stock
7914 [42]). Gad2-CreER mice express a tamoxifen-inducible Cre in
GABAergic neurons. Cre-expressing neurons were reported by the
fluorescent protein tdTomato after tamoxifen treatment at P60 (see
Section 2.3).
arcPomc/:Gad2-CreER. arcPomcþ/ mice [11] were crossed with
Gad2-CreER mice to obtain arcPomcþ/:Gad2-CreER mice. Thereafter,
arcPomcþ/:Gad2-CreER mice were mated with arcPomcþ/ mice to
obtain arcPomc/:Gad2-CreER reversible POMC-deficient mice and
obese arcPomc/ or normal weight Gad2-CreER control groups.
arcPomc/:CreER mice were obtained as described in [11]. Briefly,
the arcPomc- line was crossed with CreER transgenic mouse line (B6.
Cg-Tg[cre/Esr1]5Amc/J; The Jackson Laboratory, stock: 004682), in
which Cre is driven by a ubiquitously active CAAG promoter and
induced by tamoxifen.
2.3. CRE induction by tamoxifen
Tamoxifen (Sigma) was prepared in sesame oil (Sigma) as described
previously [43]. Gad2-CreER mice were i. p. injected with 150 mg/kg/
day tamoxifen at p60 or with 100 mg/kg/day at P25, during five
consecutive days, with a solution of 15 or 10 mg tamoxifen/mL,
respectively. CreER mice were i. p. injected with one dose of tamoxifen
(50 mg/kg).
2.4. General study design
Two cohorts of arcPomc/:Gad2-CreER mice and their control lit-
termates were generated by breeding strategies described above and
treated with tamoxifen at postnatal days 25 or 60  3 days (P25 and
P60 cohorts, respectively). Mice were individually housed within the
first week after weaning, and body weight and food intake were
registered twice a week. Basal glycemia and glucose tolerant tests
(GTTs) were measured after overnight fasting (6 pme10 am) at the 7th
(P60-PRE) and 14th weeks of age (P25 and P60-POST) by collecting
blood samples from the tail with a OneTouch glucometer (LifeScan,
Johnson & Johnson). For GTTs, mice received an i. p. injection of
glucose (2 g/kg; Sigma) as described previously [44]. Fasting-induced
hyperphagia was measured in P60-treated mice at the 15th week of
age, as described [11]. Briefly, after a 24-hour fast (10 ame10 am) ad
libitum food intake of the next 24 h was measured and expressedhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Generation of a mouse line expressing Pomc restricted to GABAergic-POMC neurons. (A) Pomc allele contains an insertion of a neomycin resistance cassette
(neo), flanked by loxP sites (triangles), interrupting Pomc neuronal enhancer activity (blue circle: nPE1 enhancer; gap after neo: Deleted nPE2 enhancer). Gad2-CreER line drives
Pomc reactivation restricted to GABAergic-POMC neurons after i. p. injection of tamoxifen (TAM) in arcPomc/:Gad2-CreER mice (rescued). The POMC-cellular specificity of Pomc
reactivation is due to the endogenous Pomc regulatory elements in the knock-in arcPomce allele. Gray circle: Pomc pituitary promoter. Arc: arcuate Pomc transcription. Black
rectangle: Pomc exon 1. (B) Representative coronal brain sections of Gad2-CreER, Pomc/, and rescued arcPomc/:Gad2-CreER mice showing ACTH immunopositive neurons.
The arrows indicate rescued POMC expression in GABAergic neurons. 3V, third ventricle; Arc: arcuate nucleus. Magnification bars: 200 mm. (C) Percentage of POMC neurons in
arcPomc/:Gad2-CreER-rescued mice (GABAergic-POMC neurons), relative to POMC neurons in Gad2-CreER control mice, at different coronal levels of the hypothalamus. The
rostrocaudal analysis shows no significant differences (OWA). Error bars:  SEM; n ¼ 3. (D) Representative coronal brain section of an arcPomc/:Gad2-CreER-rescued mice
subjected to fluorescent hybridization for Gad1 (GABAergic neurons, green) and immunohistochemistry for ACTH (POMC neurons, red). The white rectangle depicts the area of
magnified images shown below. Magnification bars: 200 mm (upper picture) and 50 mm (bottom pictures). The white arrowheads point to GABAergic-POMC neurons. (E)
Representative coronal brain section of Ai14:Gad2-CreER mice showing recombination in GABAergic cells (red, “Gad2CreER-Tom”) and ACTH immunopositive neurons (green,
“POMC”). The white rectangle depicts the area of the magnified image shown on the right. The white arrows point to GABAergic-POMC neurons. Magnification bars: 200 mm (left
picture) and 50 mm (right picture).relative to the average daily food intake of the previous week. At the
16th week of age, mice were anesthetized with 5% chloral hydrate at 3
pm and perfused with 4% paraformaldehyde (PFA) for subsequent
immunohistochemistry or in situ hybridization. Alternatively, mice were
killed by cervical dislocation at 11 am, and fresh hypothalami were
removed and fast-frozen for RNA extraction, while inguinal (unilateral)
and gonadal (bilateral) fat pads as well as livers were weighed.
2.5. Hypothalamic Pomc mRNA expression
Hypothalamic total RNA was prepared following phenol-chloroform
extraction using TriPure (Roche) and then treated with RNase-free
DNase I (Ambion). First-strand cDNA was synthesized with random
primers using High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Pomc mRNA was identified by relative quantitative RT-
PCR using PowerUp SYBR Green Master Mix (Thermo Fisher Scienti-
fic) with specific primers (F- 50-CTCCTGCTTCAGACCTCCAT-30 and R-
50-CAGTCAGGGGCTGTTCATCT-30; amplicon size: 169 bp), relative to
endogenous b-actin (primers F-50-AGAGGGAAATCGTGCGTGAC-30 and
R- 50- CAATAGTGATACCTGGCCGT-3’; amplicon size: 138bp). Samples
were run on the 7500 Real-Time PCR machine (Applied Biosystem),MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comand the results were analyzed by the 2DDCT relative quantitation
method [45].
2.6. Immunohistochemistry
PFA fixed brains were collected and cut into 35 mm coronal sections
with a frozen microtome (Leica). For immunohistochemistry, floating
brain sections were treated with 1% H2O2 for 30 min and, after PBS
washing, sections were incubated with rabbit polyclonal anti-rat-ACTH
antibody (1:1000, A.F. Parlow, National Hormone and Peptide Pro-
gram, Harbor-UCLA Medical Center, Torrance, CA, USA), overnight at
4 C. The following day, sections were incubated first with the sec-
ondary antibody (biotinylated anti-rabbit IgG made in goat, 1:200,
Vector Labs) and then with avidin-radish peroxidase complex (Vec-
tastain ABC Kit, Vector Labs). Finally, slices were developed with
diaminobenzidine (DAB) (Vector Labs), mounted on 1% gelatin (Sigma)
coated glass slides with Canada balsam, and analyzed with an
Olympus BX53 microscope, coupled with a Q-Color5 digital camera
and Capture Q software. The quantitative rostrocaudal analysis was
performed manually and blinded by two investigators,
between 1.22 mm and 2.06 mm from bregma with Fiji softwareccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
Figure 2: Pomc restoration in GABAergic-POMC neurons improves energy balance and glycemia. (A, H) Average of daily food intake from the 6th to 8th and from the 12th to 14th
weeks of age (before (PRE) and after (POST) treatment, respectively) of mice treated i. p. with tamoxifen (TAM) at P60. N¼ 9e14. (B, I) Bodyweight curves ofmice treated with TAM at P60.
Graphs on the right show comparisons of body weights before (PRE, 7 weeks old) and after (POST, 16 weeks old) TAM treatment. N ¼ 9e14. (C, J) Fast induced hyperphagia of mice
previously treatedwith TAM at P60. Bars correspond to averages of 24-hour refeeding data expressed as a percentage of prefasting food intake. The degree of hyperphagia can be estimated
above the dashed lines. N¼ 9e14. (D, K)Basal glycemiameasured before (PRE, 7weeks old) and after (POST, 14weeks old) TAM treatment. N¼ 5e9. (E-Gand L-N)Gonadal and inguinal
fat pad weights and liver weights of mice treated with TAM at P60. N¼ 4e10. (O, R) Average of daily food intake (from the 12th to 14th weeks of age) of mice treated i. p. with TAM at P25.
N¼ 4e11. (PeS)Bodyweight curves ofmice treatedwith TAMat P25. Graphs on the right showcomparisons of bodyweights before (PRE, 3weeks old) and after (POST, 16weeks old) TAM
treatment. N¼ 4e12. (Q, T)Basal glycemiameasured at the 14thweeks of age ofmice treatedwith TAMat P25. N¼ 3e9. (AeG) and (OeQ) correspond to females and (HeN) and (ReT)
correspond to males. In all cases, error bars:SEM. (A, B, D, H, I, K, P, S) RMA: *P< 0.05, **P< 0.01, ***P< 0.001; #P< 0.05, ##P< 0.01, and ###P< 0.001: pairwise comparisons
within the same group, before (PRE) versus after (POST) Pomc restoration (Bonferroni). (C, EeG, J, LeN, O, Q, R, T) OWA: *P < 0.05, **P < 0.01, and ***P < 0.001 (Bonferroni).
Original Article
4 MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Figure 3: Partial nonspecific rescue of Pomc fails to normalize food intake and body weight. (A, B) Average of daily food intake from the 6th to 8th and from the 12th to
14th weeks of age (before (PRE) and after (POST) treatment, respectively) in female (A) and male (B) mice treated i. p. with a single low dose of tamoxifen (TAM) at P60). N ¼ 4e7.
(C, D) Body weight curves of female (C) and male (D) mice. The graphs on the right show comparisons of body weights before (PRE, 7 weeks old) and after (POST, 16 weeks old)
TAM treatment. N ¼ 4e7. (E, F) Comparison of body weights of female (E) and male (F) mice before and after GABA-specific or nonspecific Pomc rescue at P60. The data of
arcPomc/:Gad2-CreER and Gad2-CreER phenotypes correspond to the same mice shown in Figure 2B (females) and Figure 2I (males). N ¼ 4e14. Error bars: SEM. RMA:
*P < 0.05, and **P < 0.01, ***P < 0.001. Pre versus Post: #P < 0.05, ##P < 0.01, and ###P < 0.001 (Bonferroni).[46]. Results were expressed as the percentage of POMCþ neurons in
arcPomc/:Gad2-CreER- or arcPomc/:CreER-rescued mice rela-
tive to POMC þ neurons in Gad2-CreER or CreER control mice,
respectively. For anti-ACTH immunofluorescence, sections were
incubated with AlexaFluor488-coupled anti-rabbit IgG (1:1000, Invi-
trogen) and colocalized with endogenous red fluorescent signal
(tdTomato) of Ai14 mice. In this case, images were obtained with an
Olympus FV1000 confocal microscope, and slices between1.34 mm
and 1.7 mm from bregma were analyzed with Fiji software.
2.7. Chromogenic (ISH) and fluorescent in situ hybridization (FISH)
For Npy probe cloning, an insert of 493 bp (NM_023456.3, 32e524
bp) was amplified by RT-PCR from RNA of mouse embryos using gene-
specific primers: mNpyF: 50 TCTCACAGAGGCACCCAGAG 30 and
mNpyR: 50 CAACAACAACAAGGGAAATG 30 . The PCR product was
cloned (pGEM-T Easy Vector, Promega, Cat. A1360) and sequenced
(SAI, University of Murcia). Gad1 probe (NM_008077.5, 2198e2949
bp) was kindly provided by Dr. Z. Katarova. For both ISH and FISH, PFA-
fixed brains were embedded in 15% gelatin (Sigma) in PBS and then
collected and cut into 20 mm coronal sections with a frozen cryostat
(Thermo Fisher Scientific). ISH was performed as described [47] with
minor modifications. Briefly, Npy probe was synthesized using a
digoxigenin- (DIG-) labeling kit (Roche), incubated with ON at 72 C,
and developed with NBT/BCIP (Roche). For FISH, mounted sections
were incubated with DIG-labeled Gad1 RNA probe overnight at 55 C.
DIG probe was detected with an anti-Dig-POD antibody (1:150, Roche)MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comand developed with Alexa-488 Tyramide Signal Amplification Kit
(1:100, Life Technologies). After FISH protocol, sections were incu-
bated with rabbit polyclonal anti-rat-ACTH antibody (1:100, A.F. Par-
low, National Hormone and Peptide Program, Harbor-UCLA Medical
Center, Torrance, CA, USA) followed either by an anti-rabbit-Cy3
antisera (1:500, Jackson ImmunoResearch, Figure 1) or by a bio-
tinylated anti-rabbit IgG antisera (1:200, Vector Labs) combined with
streptavidin-Alexa Fluor-647 (1:1000, Jackson ImmunoResearch,
Figure 6). Sections were mounted with VECTASHIELD (Vector Labs)
and analyzed with Axio Imager M2 motorized fluorescent microscope
with Apotome2 structured illumination (Zeiss). Photographs were ob-
tained with a monochromatic camera, and fluorophores were artifi-
cially colored by Neurolucida Software (MBF Bioscience). For double-
labeling analysis (Gad1þ/POMCþ), one image per hemisphere was
taken and manually analyzed with Fiji software. Results were reported
as the percentage of POMC þ neurons expressing Gad1. For triple-
labeling analysis (retrobeadsþ/Gad1þ/ACTHþ), z-stack images
were taken every 5 mm for a total of 15 mm (one per hemisphere of
arcuate nucleus). Stack images were collapsed in a unique plane and
analyzed with Fiji software. Quantitative analysis was manually per-
formed by two investigators in sections between 1.4 and 1.9 mm
distance to bregma. 32.4  2.5 POMC neurons per hemisection of the
hypothalamus were quantified. Results were expressed as the per-
centage of cells labeled with red (retrobeads) and blue (POMC) signals
(presumably POMC neurons projecting to the DMH) that were also
green (Gad1þ).ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
Figure 4: POMC fibers projecting to the dorsomedial hypothalamic nucleus (DMH) of
POMC rescued mice. (A) Schematic coronal brain section adapted from [57]. The red
rectangle signalizes the brain area shown in the upper pictures of (B) and (C). (B) Upper
panels: representative coronal brain sections ofGad2-CreERand rescuedarcPomc/:Gad2-
CreER female mice showing POMC immunopositive neurons in the arcuate nucleus (Arc) and
POMC immunoreactive fibers (POMC-IRFs) in the DMH. Magnification bars: 200 mm. (C)
Upperpanels: representative coronal brain sections of CreERand rescuedarcPomc/:CreER
female mice showing POMC immunopositive neurons in the Arc and POMC-IRFs in the DMH.
Magnification bars: 200 mm. (B and C) Bottom panels: magnified areas of DMH taken from
the upper pictures showing POMC-IRsF. Magnification bars: 50 mm.
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Red fluorescent latex microspheres (Lumafluor Inc.) were used as a
retrograde neuronal tracer to track projections to DMH. Adult wild-type
C57Bl/6 (10e12 weeks old) female mice (n ¼ 4) were anesthetized
using isoflurane in O2 (2.5% induction, 0.8% maintenance) and placed
in stereotactic head apparatus (Kopf Instruments). Ophthalmic oint-
ment was applied to both eyes to prevent drying, and 2% lidocaine
hydrochloride was injected subcutaneously for local analgesia. Multiple
rounds of betadine and 70% ethanol wipes were applied to the scalp
and then a midline 8 mm incision was made to access the skull. Then,
a 1 mm diameter craniotomy was drilled. The retrobeads solution
(500 nl, 1:200 in saline) was injected bilaterally at 100 nl/min at the
following stereotaxic coordinates: 1.7 mm anteroposterior, 1.3 mm
mediolateral relative to bregma, and 4.80 mm dorsoventral from the
cortical surface using a 10 angle to avoid ventricles and damage of
the superior sagittal sinus. After surgery, the skin was sutured and
postoperative care included analgesia (i.p. administration of flunixin
5 mg/kg) for three consecutive days. Two weeks after surgery (14e19
days), mice were perfused and brains were removed and fixed in 4%
PFA to prepare them for in situ hybridization and
immunohistochemistry.
2.9. Statistical analysis
All data are presented as the mean  SEM and were analyzed by
Student’s unpaired two-tailed t-test, one-way or two-way ANOVA
(OWA, TWA), or repeated measures ANOVA (RMA), using GraphPad
Prism version 6.00 for Windows (GraphPad Software, La Jolla Cali-
fornia, USA). Post hoc Bonferroni’s test was used when necessary.
P < 0.05 was considered significant.
3. RESULTS
3.1. Pomc expression restricted to GABAergic neurons
In order to elucidate the physiological role of POMC expressed in the
subpopulation of arcuate (Arc) GABAergic-POMC neurons, we used a
previously developed mouse model carrying a mutant conditional
Pomc allele (arcPomc-), which harbors a loxP-flanked neomycin
cassette within Pomc neuronal enhancer region, which selectively
prevents neuronal transcription in the Arc but not in the pituitary gland
or the nucleus of the solitary tract (Figure 1A and [11]). Homozygous
arcPomc/ mice are hyperphagic and develop early-onset extreme
obesity [11]. However, eutopic Pomc expression can be achieved by
crossing arcPomc/ mouse line with another one expressing Cre
recombinase [11]. Interestingly, we previously found that food intake
and body weight can be greatly improved after Pomc recovery by a
ubiquitously expressed Cre recombinase [11]. In the present study, in
order to assure Pomc expression restricted to GABAergic neurons,
arcPomc- mouse line was crossed with another knock-in line
expressing a tamoxifen-inducible Cre driven by the Gad2 promoter
(Gad2-CreER mouse line [41], Figure 1A).
In order to selectively recover Pomc expression in GABAergic neurons,
we treated arcPomc/:Gad2-CreER mice with tamoxifen at P60,
which led to POMC expression in 25.1  3.3% and 23.2  2.3%
(mean  SEM) of POMC neurons in female and male mice, respec-
tively, compared to Gad2-CreER control mice (Figure 1B,C). Moreover,
hypothalamic Pomc rescue restricted to GABAergic neurons resulted in
23.3  7.1% and 14.8  1.3% of Pomc mRNA compared to Gad2-
CreER control mice (mean  SEM) in females and males, respectively.
POMC immunopositive neurons in rescued mice showed homoge-
neous distribution across the anterioreposterior axis of the arcuate
nucleus (OWA: P > 0.05 for both sexes, Figure 1C). In order tohis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: DMH-NPY expression is normalized after POMC expression restricted to GABAergic neurons. (A, C) Coronal brain sections of mice subjected to in situ hy-
bridization, showing Npy mRNA (purple) in the dorsomedial hypothalamic nucleus (DMH) and arcuate nucleus (Arc) of the hypothalamus. 3V, third ventricle. ME: median eminence.
Magnification bars: 200 mm. (B, D) Average of DMH-Npy and Arc-Npy neurons per hemisection for each genotype. Error bars: SEM. OWA: *P < 0.05, **P < 0.01, and
***P < 0.001 (Bonferroni). N ¼ 3e4.establish the specificity of the Gad2-CreER driver, we performed
double labeling by in situ hybridization and immunohistochemistry in
brain slices of arcPomc/:Gad2-CreER mice which revealed that at
least 94.2  0.7% of rescued POMC neurons are GABAergic
(Figure 1D).
Since, according to previous quantifications of Gad2þ-POMC neurons
[39], we expected Pomc recovery in w45% of POMC neurons, to
determine the extension of Gad2-CreER activity, we generated
Ai14:Gad2-CreER reporter mice. After tamoxifen administration, we
found tdTomato expression in 26.7  1.9% (mean  SEM, n ¼ 3) of
POMC neurons (Figure 1E), which suggests incomplete recombination
induced by the Gad2-CreER driver.
3.2. GABAergic-POMC neurons regulate energy balance
With the aim of studying the role of Arc-POMC expressed in GABAergic
neurons in the regulation of energy balance, we rescued Pomc
expression in arcPomc/:Gad2-CreER mice. After tamoxifen treat-
ment at P60, we found that both female and male arcPomc/:Gad2-
CreER-rescued mice normalized food intake (Figure 2A,H). Remark-
ably, female arcPomc/:Gad2-CreER mice greatly improved body
weight after Pomc rescue: they were w70% overweight before
treatment and, after losing weight, they remain only w29% over-
weight, compared to Gad2-CreER control littermates (Figure 2B).
Furthermore, while arcPomc/ female mice showed decreased
fasting-induced hyperphagia, rescued arcPomc/:Gad2CreER mice
displayed normal response (Figure 2C). Fasting glycemia and glucose
tolerance, which were increased and decreased, respectively, in
Pomc-deficient female mice, were completely restored by PomcMOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comrecovery in GABAergic-POMC neurons (Figure 2D and Supplementary
Figures 1Ae1D). In females, body weight improvement was due to
fat loss, since inguinal and gonadal fat pads as well as liver weights
were significantly lower in arcPomc/:Gad2-CreER-rescued mice
compared to obese arcPomc/ control mice (Figure 2EeG).
ArcPomc/:Gad2-CreER male mice were rescued at P60 completely
normalized food intake (Figure 2H). However, they showed mild body
weight loss, with body weights that become significantly different from
those of arcPomc/ mice seven weeks after Pomc recovery (RMA,
Bonferroni post hoc test: P< 0.01; Figure 2I). Regarding fasting-induced
hyperphagia, while arcPomc/ male mice showed decreased food
intake in the refeeding period, rescued arcPomc/:Gad2-CreER mice
showed no significant differences with either arcPomc/ or Gad2-
CreER control mice (Figure 2J). Fasting glycemia was not increased in
Pomc-deficient male mice, at least until the 14th week of age
(Figure 2K). However, these mice were intolerant to a glucose overload,
a condition that was reverted by Pomc rescue (Supplementary
Figures 1Ee1H). Finally, weights of inguinal and gonadal fat pads of
rescued arcPomc/:Gad2-CreER male mice were not significantly
different from those of arcPomc/ or Gad2-CreER mice, while liver
weights were higher than those of Gad2-CreER mice (Figure 2LeN).
The above results show that the Pomc expression in GABAergic-POMC
neurons is sufficient to maintain normal food intake. However, despite
Pomc rescue in obese mice at P60 leads to body weight loss,
arcPomc/:Gad2-CreER-rescued mice remain heavier than Gad2-
CreER littermates. Since we previously found that Pomc recovery by a
ubiquitously expressed CreER only leads to normal body weight when
tamoxifen is injected to normal weight mice [11], we sought toccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
Figure 6: Arcuate POMC neurons projecting to DMH are mainly GABAergic. (A) Representative image of coronal brain sections showing bilateral injection of retrobeads (red)
in the DMH of a wild-type female mouse. Magnification bar: 200 mm. (B) Representative fluorescent microphotograph of a coronal brain section at 1.58 mm from bregma,
subjected to POMC immunostaining (blue) and in situ hybridization against Gad1 (green). Red: retrobeads coming from the DMH. Magnification bar: 200 mm. (CeF) Magnified
images of the square shown in (B). Arc: arcuate nucleus. 3V: third ventricle. Magnification bar: 50 mm.
Table 1 e Brain areas with GABAergic POMC-immunopositive fibers
(POMC-IRF). Numbers indicate the quantity of arcPomc/:Gad2-CreER
female and male mice rescued at P60 showing POMC-IRF projecting to a
specific brain area, from a total of 6 analyzed mice.
BRAIN AREAS WITH POMC-IRF FEMALES MALES
Dorsomedial hypothalamic nucleus 6 6
Paraventricular hypothalamic nucleus 4 4
Posterior hypothalamic nucleus 3 4
Bed nucleus of the stria terminalis 2 3
Periventricular hypothalamic nucleus 0 2
Paraventricular thalamic nucleus 2 0
Anterior commissure 2 0
Suprachiasmatic nucleus 0 2
Preoptic nucleus 1 1
Tuber cinereum area 1 0
Lateroanterior hypothalamic nucleus 1 0
Retrochiasmatic area 1 0
Premammillary nucleus 1 0
Original Articleelucidate if Pomc rescue restricted to GABAergic-POMC neurons in
juvenile mice has similar consequences. Therefore, another cohort of
mice was injected with tamoxifen at P25, before the onset of obesity.
The magnitude of Pomc recovery in arcPomc/:Gad2-CreER mice at
P25 was similar to that of mice treated at P60: 22.31  1.83% and
26.17  3.94% (mean  SEM) of POMC þ cells compared to control
Gad2-CreER mice in females and males, respectively. We found that
Pomc rescue in GABAergic-POMC neurons at P25 prevented hyper-
phagia in females and decreased hyperphagia in male arc-
Pomc/:Gad2-CreER mice compared to arcPomc/ controls
(Figure 2O,R). Moreover, Pomc rescue at P25 delayed the onset of
obesity in both female and male arcPomc/:Gad2-CreER mice: while8 MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. TarcPomc/ mice became significantly heavier than Gad2-CreER
control mice since the 7th and 4th week of age (RMA, Bonferroni post
hoc test: P < 0.001 and P < 0.05, female and male, respectively),
both female and male arcPomc/:Gad2-CreER mice rescued at P25
became overweight only since the 9th week of age (RMA, Bonferroni
post hoc test: P < 0.05 for both sexes; Figure 2P,S). Finally, Pomc
rescue at P25 prevented hyperglycemia in both female and male
arcPomc/:Gad2-CreER mice (Figure 2Q,T). Altogether, these results
suggest a key role of GABAergic-POMC neurons in the control of en-
ergy balance.
3.3. Partial nonspecific Pomc rescue leads to mild body weight
improvement
In order to emphasize the significance of GABAergic-POMC neurons
in the regulation of energy balance, we compared the improvement of
obesity after Pomc rescue, specifically in GABAergic neurons, with
that achieved by rescuing POMC in a similar number of neurons but
in a nonspecific manner. With the purpose of inducing partial Pomc
rescue driven by a ubiquitously expressed Cre recombinase, we
generated arcPomc/:CreER mice and treated them with a single
dose of tamoxifen (50 mg/kg) at P60. Tamoxifen treatment led to
32  3.6% and 35.2  7.2% (mean  SEM; females and males,
respectively) of POMC þ neurons in arcPomc/:CreER mice
compared to CreER controls (Supplementary Figure 2). Contrary to
Pomc rescue in GABAergic neurons, nonspecific Pomc rescue failed
to improve food intake in both female and male arcPomc/:CreER
mice (Figure 3A,B). Furthermore, nonspecific POMC rescue led to a
mild loss of body weight in both female and male arcPomc/:CreER
mice compared to arcPomc/ mice (Figure 3C,D). Remarkably, body
weight was significantly lower after Pomc rescue in GABAergic
neurons compared to the nonspecific rescue (Figure 3E,F). Moreover,his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 7: Model of an arcuate GABAergic-POMC / DMH-NPY circuit for the
regulation of food intake. Upper panel: in wild-type mice (Pomcþ), GABAergic-POMC
neurons (red-filled circles with G) of the arcuate nucleus (Arc) suppress food intake by
inhibiting NPY expression in dorsomedial hypothalamic nucleus (DMH) neurons (green
open circles), maintaining a normal weight. Middle panel: in Pomc knockout mice
(Pomc), lack of Pomc expression in Arc neurons (red-open circles) results in DMH-
NPY expression (green-filled circles) and increased food intake and obesity. Lower
panel: Pomc expression restricted to GABAergic neurons (PomcGABA) recovers NPY
inhibition resulting in normal food intake and weight loss.while arcPomc/:Gad2-CreER mice maintained or decreased body
weight compared to their pretreatment stage (female and male,
respectively), arcPomc/:CreER mice further increased body weight
after Pomc nonspecific rescue (Figure 3E,F). Altogether, the com-
parison of obesity improvement after GABAergic-specific versus
nonspecific Pomc expression suggests a preponderant role of
GABAergic-POMC neurons in the regulation of food intake and body
weight.
3.4. Distribution of GABAergic-POMC immunoreactive fibers
In order to dissect the anatomical distribution of GABAergic-POMC
immunoreactive fibers (POMC-IRFs), coronal and sagittal brain sec-
tions of rescued arcPomc/:Gad2-CreER mice were subjected to
immunohistochemistry against ACTH. As expected, since POMC is
rescued in only w25% of the total POMC neurons in these mice, in
general, few isolated POMC-IRFs were detected. Remarkably, we
consistently found POMC-IRFs in the DMH of all analyzed female and
male rescued arcPomc/:Gad2-CreER mice (Table 1, Figure 4B, and
Supplementary Figure 3). To a lesser extent, paraventricular hypo-
thalamic nucleus and the posterior hypothalamic nucleus, which are
highly innervated by POMC neurons in wild-type mice, were also the
main target sites of GABAergic-POMC neurons (Table 1 and
Supplementary Figure 3). Surprisingly, other areas that are highly
innervated by POMC neurons in wild-type mice showed POMC-IRFs
only in a few proportion of arcPomc/:Gad2-CreER-rescued mice
(e.g., the bed nucleus of the stria terminalis, retrochiasmatic area, and
the periventricular hypothalamic nucleus) (Table 1). On the contrary, all
male and female Gad2-CreER control mice showed POMC-IRFs in the
brain areas listed in Table 1 (n ¼ 3 and 6, males and females,
respectively; data not shown).
3.5. Pomc rescue in GABAergic-POMC neurons prevents DMH-Npy
overexpression
Since we found that the DMH is a major target site of GABAergic-POMC
neurons and there is some evidence suggesting that DMH-NPY neu-
rons induce food intake in different models of obese mice, including
MC4-RKO [28e31], we hypothesized that POMC expression restricted
to GABAergic neurons could normalize food intake by inhibiting DMH-
NPY expression. In order to study if there is a correlation between
DMH-Npy expression and Arc-POMC expression, we performed in situ
hybridization (ISH) for Npy in the brains of female mice previously
treated with tamoxifen at P60 (Figure 5). As expected for normal-
weight mice, Gad2-CreER mice showed very low expression in the
DMH (Figure 5A,B). However, DMH-Npy expression raised more than
30 times in obese arcPomc/ mice compared to Gad2-CreER sib-
lings. Interestingly, DMH-Npy expression was reestablished by Pomc
expression restricted to GABAergic-POMC neurons in arc-
Pomc/:Gad2-CreER-rescued mice (Figure 5A,B).
Partial nonspecific Pomc rescue also led to DMH-Npy reduction
(Figure 5C,D) and POMC-IRFs in the DMH of arcPomc/:CreER mice
(Figure 4C). However, contrary to GABAergic-specific Pomc rescue
(which leads to DMH-Npy normalization), the expression remains
higher in arcPomc/:CreER mice compared to CreER controls
(Figure 5D).
It is important to note that while the number of DMH-NPY neurons is
increased in arcPomc/ mice, the number of Arc-NPY neurons is not
significantly altered (Figure 5B,D). This finding suggests a prepon-
derant role for POMC in the regulation of DMH-NPY expression
compared to Arc-NPY expression.
In order to characterize Arc-POMC/DMH projections, we performed a
triple labeling experiment in coronal brain sections of wild-type mice.MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comFirst, neurons projecting to the DMH were labeled by stereotactic
guided injections of retrobeads (RBs) to the DMH of anesthetized mice
(n[4). Two weeks later, POMC neurons were identified by immu-
nohistochemistry and GABAergic neurons, by in situ hybridization with
a Gad1 probe, in fixed coronal brain sections of injected mice
(Figure 6A). Our results show that 16.5  2.0% (mean  SEM) of Arc-
POMC neurons are RBþ, which presumably project to the DMH.
Notably, 74.9  5.4% (mean  SEM) of POMCþ/RBþ neurons are
Gad1þ, revealing that most of Arc-POMC/DMH projections are
GABAergic (Figure 6BeF). Altogether, these results support the hy-
pothesis of an inhibitory tone of arcuate GABAergic-POMC neurons onccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Original ArticleDMH-NPY expression which may contribute to normal control of food
intake.
4. DISCUSSION
In the present study, we show that the subpopulation of arcuate
GABAergic-POMC neurons is involved in body weight regulation.
Moreover, we found that the DMH is a major target site of GABAergic-
POMC neurons followed by the PVN. In addition, we found that DMH-
NPY expression is highly increased in POMC-deficient mice and it can
be restored by Pomc expression restricted to GABAergic-POMC neu-
rons. Finally, we determined that Arc-POMC neurons projecting to the
DMH are mainly GABAergic.
Two previous studies showed the physiological consequences of
arcuate Pomc expression restricted to well-defined subpopulations.
Burke et al. showed that congenital Pomc expression in the subpop-
ulation of neurons expressing 5-hydroxytryptamine 2c receptor (5-
HT2CR), which encompasses about 40% of POMC neurons, prevents
hyperphagia in both sexes and obesity in male mice [48]. In another
study, it was shown that constitutive Pomc expression restricted to
neurons expressing the leptin receptor (50%e80% of POMC neurons)
leads to normal food intake and body weight [49]. In these studies,
Pomc expression was recovered in 40%e70% of POMC neurons
leading to more than 40% of Pomc mRNA expression, which is
consistent with previous data showing that there is a threshold of 30%
of Pomc mRNA and 30% of POMC þ neurons above which mice
maintain normal food intake and body weight [50,51]. In this regard,
here we show the first example of food intake normalization in adult
mice with less than 25% of hypothalamic Pomc mRNA expression. It is
important to note that, in the present work, we show improvement of
obesity phenotype by Pomc rescue in postnatal life rather than pre-
vention of hyperphagia and overweight by Pomc expression during
embryological development. Moreover, by inducing Cre activity in adult
mice, we bypassed the developmental stage in which shifts between
glutamate and GABA expression can occur, as has been previously
shown for POMC neurons [52,53]. Most importantly, we found that
Pomc expression in only 23%e25% of POMC neurons restricted to the
GABAergic subpopulation has a similar impact as the nonspecific
rescue of Pomc in w75% of POMC neurons, in mice treated at P60
(compared to [11]).
Although it has been previously shown that Gad2þ POMC cells
encompass w50% of Arc-POMC neurons [39,40], Gad2-CreER driver
induced Pomc expression only inw23e25% of POMC neurons. Since
we found similar results in Ai14:Gad2-CreER (only w26% of POMC
neurons were dtTomatoþ), the incomplete Pomc recovery may be
attributed to low Cre expression in the knock-in mouse line, or to
incomplete tamoxifen bioavailability, or both. In either case, it is
interesting to note that Pomc expression restricted to half of
GABAergic-POMC neurons is enough to normalize food intake, while
partial nonspecific POMC rescue in arcPomc/:CreER mice, with
w32e35% of POMC neurons expressing Pomc, is not. These results
suggest that GABAergic-POMC neurons have a key role in the regu-
lation of food intake.
We previously found that Pomc recovery in arcPomc/:CreER at
P25 completely prevented obesity [11]. Conversely, arc-
Pomc/:Gad2-CreER mice treated at P25, despite showing lower
body weight and food intake than arcPomc/ mice, become
overweight by the 9th week of age. However, since only half of
GABAergic-POMC neurons recovered Pomc expression in these10 MOLECULAR METABOLISM 37 (2020) 100985  2020 The Authors. Published by Elsevier GmbH. Tmice, we cannot exclude that this subpopulation could be sufficient
to maintain normal body weight in wild-type mice. Moreover, the
participation of glutamatergic-POMC neurons in the regulation of
energy balance cannot be ruled out. In this regard, Jones et al.
rescued Pomc expression in arcPomc/ mice with a Vglut2-Cre
driver constitutively expressed since the embryological develop-
mental period [53]. However, they found Pomc expression also in
GABAergic neurons, probably because of the postnatal shift from
glutamate to GABAergic subpopulation.
Regarding glucose homeostasis, female arcPomc/ and arc-
Pomc/:Gad2-CreER mice show fasting hyperglycemia when they
are 7 weeks old. Interestingly, only rescued arcPomc/:Gad2-CreER
mice normalized glycemia after tamoxifen treatment. In addition, both
female and male Pomc-deficient mice were intolerant to a glucose
overload, a condition that was reverted by Pomc rescue. These results
can be attributed not only to body weight loss but also to Pomc re-
covery in GABAergic-POMC neurons, since we previously showed that
normal-weight arcPomc/:CreER female mice are intolerant to
glucose overload and display decreased insulin sensitivity, both con-
ditions that can be reverted by Pomc rescue [44].
Our results show that a major target site of GABAergic-POMC neurons is
the DMH, which is known to be involved in the regulation of food intake
and energy expenditure. In mice, DMH-Npy mRNA expression is only
found in some models of genetic or high-fat diet-induced obesity and in
mice subjected to chronic energy restriction. For example, Ay obesemice,
which have an ectopic expression of the orexigenic agouti-signaling
protein, show Npy mRNA expression in DMH [29]. It has been sug-
gested that DMH-Npy mRNA expression may be caused by agouti inhi-
bition of MC3/4R in DMH neurons. This hypothesis is supported by results
showing that targeted disruption of the MC4-R gene leads to increased
expression ofNpymRNA in the DMH [29]. Moreover, injection ofMC3/4R-
selective agonist melanotan II (MTII) in the DMH suppresses fasting or
suckling-induced hyperphagia and suckling-induced Npy mRNA
expression in the DMH of lactating rats [54]. Finally, a-MSH analog de-
creases food intake 1 h after injection in the DMH [55].
Although it is clear that MC3/4R stimulation inhibits DMH-Npy mRNA
expression, it remained to be elucidated if Arc-POMC neurons mediate
this regulation. Here, we show that obese arcPomc/mice exhibit highly
increased DMH-NpymRNAexpression.Wepropose that inwild-typemice
a-MSH and/or other neuropeptides derived from POMC are secreted by
Arc-POMC neurons and, by interacting with postsynaptic receptors (either
directly on DMH-NPY neurons or indirectly on other DMH-intermediate
neurons), inhibit DMH-NPY expression assuring normal food intake and
body weight (Figure 7, upper panel). Accordingly, Pomc deficiency in
arcPomc/mice would lead to DMH-NpymRNA overexpression which,
in turn, would contribute to hyperphagia and obesity (Figure 7, middle
panel). Finally, given that, as we found, w75% of Arc-POMC neurons
projecting to the DMH are GABAergic, it is probable that the normalization
of DMH-NPY expression after Pomc restoration in GABAergic neurons
accounts for food intake normalization leading to body weight loss
(Figure 7, lower panel). This model could also explain the reduction in
DMH-Npy expression in partially rescued arcPomc/:CreER mice, since
we expect w40% of neurons recovering POMC with the nonspecific
driver to be GABAergic. However, we cannot exclude a contribution of
non-GABAergic neurons to the inhibition of DMH-Npy expression either in
these mice or in wild-type mice. In addition, the Arc-POMC/ DMH-NPY
inhibition may also be involved in the regulation of fasting-induced hy-
perphagia, which is also disrupted in arcPomc/ mice and restored by
Pomc rescue in GABAergic-POMC neurons. Although close appositionshis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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between a-MSH-immunoreactive fibers and DMH-NPY neurons were
previously observed in female rats [54], it remains to be elucidated if Arc-
POMC neurons synapse with DMH-NPY neurons in mice. Alternatively,
Arc-POMC-derived peptides may exert an indirect inhibitory regulation of
DMH-Npy mRNA expression. Although here we propose that food intake
may be regulated by an Arc-GABAergic-POMC/ DMH-NPY pathway, an
Arc-GABAergic-POMC / PVN circuit may also be involved in the
normalization of food intake in rescued mice. In this regard, we found
POMC-IRFs in the PVN of rescuedmice and it has been demonstrated that
POMC projections in the PVN increase the activity of MC4R neurons
leading to a decrease in food intake [56].
In summary, our results show that the subpopulation of Arc-
GABAergic-POMC neurons is a major regulator of food intake and
body weight. Since Pomc reactivation in these neurons normalizes
DMH-NPY expression and food intake, the circuit between Arc-POMC
and DMH-NPY neurons could be a potential target for the treatment
of obesity.
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